Recombinant Mycobacterium bovis BCG

被引：73

作者：

Bastos, Reginaldo G. ^{[2
]}

Borsuk, Sibele ^{[1
]}

Seixas, Fabiana K. ^{[1
]}

Dellagostin, Odir A. ^{[1
]}

机构：

[1] Univ Fed Pelotas, Ctr Biotecnol, Mol Biol Lab, BR-96010900 Pelotas, RS, Brazil

[2] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA

来源：

VACCINE | 2009年 / 27卷 / 47期

关键词：

Mycobacterium bovis BCG; Recombinant BCG; Heterologous expression; Immunomodulator; BACILLUS-CALMETTE-GUERIN; HUMAN-IMMUNODEFICIENCY-VIRUS; SURFACE PROTEIN-A; CELLULAR IMMUNE-RESPONSES; EXPRESSING INTERFERON-GAMMA; RESPIRATORY-SYNDROME-VIRUS; GLUTATHIONE-S-TRANSFERASE; CYTOTOXIC T-LYMPHOCYTES; LYME-DISEASE VACCINE; PROTECTIVE IMMUNITY;

D O I：

10.1016/j.vaccine.2009.08.044

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The Bacillus Calmette-Guerin (BCG) is an attenuated strain of Mycobacterium bovis that has been broadly used as a vaccine against human tuberculosis. This live bacterial vaccine is able to establish a persistent infection and induces both cellular and humoral immune responses. The development of mycobacterial genetic systems to express foreign antigens and the adjuvanticity of BCG are the basis of the potential use of this attenuated mycobacterium as a recombinant vaccine. Over the years, a range of strategies has been developed to allow controlled and stable expression of viral, bacterial and parasite antigens in BCG. Herein, we review the strategies developed to express heterologous antigens in BCG and the immune response elicited by recombinant BCG constructs. In addition, the use of recombinant BCG as an immunomodulator and future perspectives of BCG as a recombinant vaccine vector are discussed. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6495 / 6503

页数：9

共 50 条

[1] Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
Chapman, Rosamund
Chege, Gerald
Shephard, Enid
Stutz, Helen
Williamson, Anna-Lise
CURRENT HIV RESEARCH, 2010, 8 (04) : 282 - 298
[2] Novel vaccination strategies based on recombinant Mycobacterium bovis BCG
Dietrich, G
Viret, JF
Hess, J
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 292 (7-8) : 441 - 451
[3] Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer
K. R. Begnini
J. H. Buss
T. Collares
F. K. Seixas
Applied Microbiology and Biotechnology, 2015, 99 : 3741 - 3754
[4] Recombinant Mycobacterium bovis BCG for new candidate vaccines against AIDS
Winter, N
RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2000, : 113 - 114
[5] Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer
Begnini, K. R.
Buss, J. H.
Collares, T.
Seixas, F. K.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 99 (09) : 3741 - 3754
[6] RECOMBINANT INTERLEUKIN-2 LIMITS THE REPLICATION OF MYCOBACTERIUM LEPRAEMURIUM AND MYCOBACTERIUM BOVIS BCG IN MICE
JEEVAN, A
ASHERSON, GL
LYMPHOKINE RESEARCH, 1988, 7 (02): : 129 - 140
[7] Molecular detection of Mycobacterium bovis and Mycobacterium bovis BCG (Pasteur) in soil
Young, JS
Gormley, E
Wellington, EMH
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (04) : 1946 - 1952
[8] SECRETION OF HUMAN INTERLEUKIN-2 BY RECOMBINANT MYCOBACTERIUM-BOVIS BCG
KONG, DQ
KUNIMOTO, DY
INFECTION AND IMMUNITY, 1995, 63 (03) : 799 - 803
[9] A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein
Luo, Y
Szilvasi, A
Chen, XH
DeWolf, WC
ODonnell, MA
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (06) : 761 - 768
[10] Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae
Makino, Masahiko
Maeda, Yumi
Inagaki, Katsuya
INFECTION AND IMMUNITY, 2006, 74 (11) : 6264 - 6271

← 1 2 3 4 5 →